Dr. Wei Ling Lau, MD

Dr. Lau practices at Fresenius Kidney Care University Dialysis Center Of Orange in Orange, California.

Dr. Lau's NPI, 1558572032, was assigned on May 25, 2007. Dr. Lau graduated from WashU Medicine in 2005. Dr. Lau holds California license A98505.

Dr. Lau's primary practice is Fresenius Kidney Care University Dialysis Center of Orange, at 1809 West Chapman Avenue, Orange, CA 92668 in Orange County. The practice phone is (714) 456-5555.

Dr. Lau's primary practice is Fresenius Kidney Care University Dialysis Center Of Orange in Orange, California. Dr. Lau is also affiliated with UCI Health - Orange. The medical group on file is UCI Health Physicians. Dmand AI also links Dr. Lau to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Lau practices, 3 sites in all. Vendor and product names are available with a free account.

Nephrology is Dr. Lau's primary specialty in the NPI Registry, under taxonomy code 207RN0300X. Dr. Lau is board certified in internal medicine by the American Board of Internal Medicine. Dmand AI has Dr. Lau's licenses on file in 2 states: California and Washington.

Dmand AI lists acute kidney failure, chronic anemia, chronic kidney disease, fluid and electrolyte imbalances and parathyroid gland disorder among the conditions Dr. Lau treats.

CMS data shows 866 Medicare services from Dr. Lau across 14 procedure codes in 2024, for 266 Medicare patients. Medicare paid $115,501 for them.

CMS counts 266 Medicare patients who saw Dr. Lau in 2024. The largest group is 65 to 74, with 94 patients. 75% of them have chronic kidney disease, and 75% have high blood pressure. 42% are also on Medicaid. Their average risk score is 5.28, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Lau's median patient age at 65, with 40% women.

In 2024, Dr. Lau wrote 938 Medicare Part D claims for 119 patients. 84% of them were for generic drugs. CMS names the drug for 749 of them, across 30 drugs with 11 or more claims each, at $288,653 in total drug cost. In 2023, CMS named 617 claims across 26 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Lau for performance year 2024, reported through an alternative payment model (APM). Dr. Lau accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Lau as offering telehealth.

Dmand AI links 75 papers to Dr. Lau, published from 2007 to 2025. 2016 was the busiest year, with 7. The most frequent topics are Renal Insufficiency, Chronic, Renal Dialysis and Kidney Failure, Chronic. Dr. Lau has published most often in Nephrol Dial Transplant. Dr. Lau's most frequent co-authors are Kamyar Zadeh Kalantar-Zadeh, MD, Connie Meeyoung Rhee, MD and Csaba Pal Kovesdy, MD.

Dmand AI links Dr. Lau to 1 clinical trial. Conditions studied include Emergencies and Disease Attributes.

CMS Open Payments shows 51 general payments to Dr. Lau from 18 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 32% of the total. Fresenius USA Marketing, Inc. paid the most, $5,097.

Dmand AI lists 1 award for Dr. Lau.

Dr. Lau graduated from WashU Medicine in 2005. Dr. Lau is a member of ACP, AHA and ASN.

Dr. Lau is in network with 7 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Elevance. Medicare plans come from the most carriers, 7. Check the plan with the practice before a visit.